Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling.
Phosphodiesterases (PDEs) modulate the cellular proliferation involved in the pathophysiology of pulmonary hypertension (PH) by hydrolyzing cAMP and cGMP. The present study was designed to determine whether any of the recently identified PDEs (PDE7-PDE11) contribute to progressive pulmonary vascular...
Main Authors: | Xia Tian, Christina Vroom, Hossein Ardeschir Ghofrani, Norbert Weissmann, Ewa Bieniek, Friedrich Grimminger, Werner Seeger, Ralph Theo Schermuly, Soni Savai Pullamsetti |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-04-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21494592/pdf/?tool=EBI |
Similar Items
-
Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis
by: Klepetko Walter, et al.
Published: (2010-10-01) -
Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice.
by: Michael Seimetz, et al.
Published: (2015-01-01) -
Glycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.
by: Piotr Sklepkiewicz, et al.
Published: (2011-04-01) -
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
by: Ghofrani Hossein A, et al.
Published: (2010-05-01) -
Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration
by: Weissmann Norbert, et al.
Published: (2005-11-01)